Panel Discussion: Injectables in focus – Therapeutic areas driving market growth
Injectable Innovations Conclave 2025 | 11th July 2025 | Hyderabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Aspire Impact and Aspire Circle launch ESG Framework for Pharma & Healthcare
Framework unveiled in New Delhi by 15 co-authors, corporate and investment CXOs, from Cipla, Zydus, Sun Pharma, Quadria Capital,…
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment
Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop, manufacture and supply…
Gerresheimer achieves A-Score in CDP Rating
Rating recognises transparent management of CO2 emissions
AATec Medical, Northway Biotech partner to develop industrial production process for ATL-105…
Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action
Indian pharma industry profitability improves as pricing environment eases: Equirus Capital
Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…
Sun Pharma settles with Incyte Corporation in litigation relating to LEQSELVI
The parties will seek dismissal of the pending LEQSELVI litigation in the United States District Court for the District of New…
AstraZeneca gains CDSCO approval for treatment of muscle-invasive bladder cancer
Durvalumab in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Durvalumab as adjuvant…
Lilly partners with API to launch a CME for obesity
The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData
Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…